Home  »  Our work  »  Current phase: 2016-2020

Current phase: 2016-2020

Almost 4,000 patients with specific medical conditions have received genomic sequencing, in tandem with their usual care, since Melbourne Genomics commenced.

In the current program (2016-2020), more than 3,500 patients received genomic testing, for one of 11 medical conditions; a further 315 patients were tested for one of five conditions during the Demonstration Project (2014-2015). Recruitment for all clinical projects is now complete and all patients have received their genomic results.

Overall, 19 times more patients received informative results through genomic sequencing, compared to usual care for their condition. More than four in every 10 patients tested for cancer or rare disease received informative results; more precise care was the outcome for half of those with informative results.

Through 11 clinical projects in the current program, we investigated whether genomic testing could provide:

Quicker and more accurate diagnosis, leading to better care for:
More precise diagnosis and treatment for:

Improved understanding

Patients with particular conditions were invited to participate through The Royal Melbourne Hospital, The Royal Children’s Hospital, Peter MacCallum Cancer Centre, Austin Health and Monash Health.

Teams of doctors, genetic counsellors, health service researchers and scientists from across the Alliance are now evaluating patients' outcomes and experience to determine the impact genomics can have on medical care.

Melbourne Genomics is providing the results of this work to the Victorian Government to inform healthcare planning and resourcing.

Peer-reviewed publications resulting from our current program are added to the Publications page as they appear.